VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SNNSmith & Nephew plc
$30.04$12.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSNNBalance Sheet

Smith & Nephew plc (SNN) Balance Sheet

30Y historyFree accessUpdated daily

The company maintains a conservative debt-to-equity ratio of 0.63 as of 2025Q4, providing sufficient flexibility despite the $3.1 billion in goodwill on the balance sheet.

SNN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets4.1B4.42B4.03B3.86B4.42B4.66B3.22B3.08B2.73B2.53B2.48B2.44B2.26B2.14B2.21B2.15B2.08B1.99B1.92B1.65B1.56B1.22B1.06B858.02M765.09M797.29M1B947.63M927.89M966.71M
Cash & Short-Term Investments557M619M302M350M1.29B1.76B277M365M169M100M120M93M137M178M184M207M192M145M170M346M151M62.53M46.43M36.24M43.69M36.74M162.58M82.83M94.39M137.86M
Cash Only557M619M302M350M1.29B1.76B277M365M169M100M120M93M137M178M184M207M192M145M170M346M151M62.53M46.43M36.24M43.69M36.74M162.58M82.83M94.39M137.86M
Short-Term Investments000000000000000000000000000000
Accounts Receivable1.43B1.21B1.06B1.03B971M911M1.08B1.1B1.06B988M939M968M935M1.05B1.02B00014M0481M585.15M498.54M18.36K039.26K0230.51K0409.97M
Days Sales Outstanding84.4275.8369.6671.886872.9276.8682.1780.8977.2473.9676.5378.4492.986.85---1.52-68.889.1986.440-0.01-0.05-81.73
Inventory2.12B2.39B2.4B2.21B1.84B1.69B1.61B1.4B1.3B1.24B1.22B1.18B1.01B901M859M923M933M879M834M619M557M546.46M411.79M369.65M338.13M340.84M384.37M402.36M373.11M393.53M
Days Inventory Outstanding390.92493.91505.3522.61436.2442.13440.29392.28381.38356.97388.63370.97333.81307.35275.03326.77330.63297.9306.25293.8290.02310.6243.9253.79242.01-----
Other Current Assets-99M81M182M198M240M219M171M144M120M124M115M100M88M992M80M1.02B14M899M834M630M567M297M280M407.71M383.27M368.12M416.02M429.27M431.13M0
Total Non-Current Assets6.35B5.93B5.96B6.11B6.5B6.35B6.08B4.98B5.13B4.82B4.69B4.87B3.56B3.5B2.54B2.58B2.48B2.52B2.54B1.59B1.42B1.7B1.17B1.14B833.67M640.61M584.15M555.07M499.24M474.88M
Property, Plant & Equipment1.64B1.42B1.47B1.46B1.51B1.45B1.32B1.06B1.05B982M932M891M816M793M783M787M753M725M742M635M589M556.81M460M412.02M356.77M375.04M437.59M484.19M466.18M442.68M
Fixed Asset Turnover3.77x4.09x3.77x3.58x3.44x3.15x3.88x4.62x4.54x4.75x4.97x5.18x5.33x5.22x5.45x5.03x5.01x5.24x4.54x4.38x4.33x4.30x4.58x4.34x4.42x4.52x4.14x3.61x3.72x4.14x
Goodwill3.11B3.03B2.99B3.03B2.99B2.93B2.79B2.34B2.37B2.19B2.01B2.03B1.26B1.19B1.1B1.1B1.09B1.19B1.23B640M582M000000000
Intangible Assets882M1.03B1.11B1.24B1.4B1.49B1.57B1.21B1.37B1.41B1.5B1.75B1.05B1.06B423M426M412M376M419M191M91M719.85M481.07M510.91M273.47M229.72M119.71M46.97M31.91M31.34M
Long-Term Investments151M16M24M58M380M250M216M231M201M137M128M117M109M118M-125M13M6M000-123M48.64M-116.79M0035.85M26.85M23.9M1.16M856.25K
Other Non-Current Assets228M103M361M153M15M33M35M16M16M013M7M183M173M142M28M14M19M20M10M133M241.38M266.07M212.13M203.43M-36.74M-162.58M-82.83M-94.39M-137.86M
Total Assets10.46B10.35B9.99B9.97B10.92B11.01B9.3B8.06B7.87B7.34B7.17B7.31B5.82B5.64B4.75B4.73B4.57B4.51B4.46B3.23B2.98B2.92B2.22B1.99B1.6B1.44B1.59B1.5B1.43B1.44B
Asset Turnover0.59x0.56x0.56x0.52x0.48x0.41x0.55x0.61x0.61x0.64x0.65x0.63x0.75x0.73x0.90x0.84x0.83x0.84x0.76x0.86x0.86x0.82x0.95x0.90x0.99x1.18x1.14x1.16x1.21x1.27x
Asset Growth %0.99%3.67%0.21%-8.74%-0.84%18.42%15.39%2.45%7.11%2.47%-1.9%25.55%3.14%18.85%0.3%3.68%1.26%1.05%38.07%8.57%1.94%31.35%11.52%24.66%11.22%-9.36%5.53%5.29%-1%13.29%
Total Current Liabilities1.59B1.53B2.27B1.72B2.13B1.69B1.56B1.47B1.35B1.35B1.34B1.16B1.07B930M1.14B914M863M968M2.29B816M1.01B828.99M566.43M508.82M623.98M603.42M599.2M623.45M590.99M617.87M
Accounts Payable1.16B1.08B1.02B1.03B1.04B891M941M854M873M807M808M807M751M646M549M617M596M544M508M405M426M153M133M227.87M211.29M171.35M207.63M213.1M198.7M199.51M
Days Payables Outstanding214.21223.88214.36243.89246.72232.96256.7240.15255.32231.57258.02253.49249.2220.36175.78218.43211.2184.36186.54192.23221.8186.9678.77156.44151.23-----
Short-Term Debt83M2M710M111M435M279M26M167M29M85M44M37M42M36M303M57M45M115M1.44B119M227M32M173.21M244.79M160.91M122.61M93.72M143.7M147.29M188.72M
Deferred Revenue (Current)0000000223M149M154M229M187M150M167M190M203M173M-63M-37M-16M171M-8.67M-410.71M-472.65M69.31M00000
Other Current Liabilities85M126M261M526M597M460M551M444M444M454M490M316M278M69M109M37M55M117M338M292M359M534.99M188.21M36.17M182.46M310.11M297.15M266.65M56.7M50.69M
Current Ratio2.57x2.89x1.77x2.25x2.08x2.76x2.06x2.10x2.03x1.88x1.84x2.10x2.10x2.31x1.94x2.36x2.42x2.05x0.84x2.02x1.54x1.48x1.86x1.69x1.23x1.32x1.67x1.52x1.57x1.56x
Quick Ratio1.25x1.33x0.72x0.96x1.21x1.76x1.03x1.15x1.06x0.95x0.94x1.08x1.16x1.34x1.18x1.35x1.33x1.14x0.47x1.26x0.99x0.82x1.14x0.96x0.68x0.76x1.03x0.87x0.94x0.93x
Cash Conversion Cycle261.14345.85360.6350.61257.48282.09260.46234.3206.94202.63204.57194163.05179.89186.1---121.22-137312.82251.5697.35------
Total Non-Current Liabilities3.57B3.56B2.5B2.99B3.22B4.04B2.59B1.72B1.88B2.04B1.86B2.1B699M828M422M1.05B1.52B1.84B357M241M529M744.02M511.96M651.04M385.6M434.19M94.15M73.37M73.56M78.09M
Long-Term Debt3.03B3.12B2.17B2.56B2.71B3.2B1.85B1.3B1.42B1.56B1.43B1.66B335M416M1M642M1.12B1.36B36M0196M292.7M194.64M264.61M246.83M267.21M32.64M21.25M24.14M22.78M
Capital Lease Obligations149M135M144M147M141M157M124M005M8M10M12M14M15M000015M15M000000000
Deferred Tax Liabilities40M31M9M36M144M141M167M99M97M94M77M98M50M61M66M69M31M46M57M35M48M78.45M110.54M90.2M083.04M0000
Other Non-Current Liabilities356M300M180M244M229M551M452M419M453M474M423M438M352M337M27M262M322M437M264M191M139M204.57M279.32M296.19M138.78M83.94M61.51M52.12M49.43M55.31M
Total Liabilities5.17B5.09B4.77B4.71B5.35B5.73B4.16B3.19B3.22B3.39B3.2B3.27B1.77B1.76B1.56B1.96B2.39B2.81B2.65B1.06B1.54B1.57B1.08B1.16B1.01B1.04B693.35M696.82M664.55M695.96M
Total Debt3.33B3.32B3.08B2.87B3.34B3.69B2.05B1.47B1.45B1.65B1.48B1.71B391M468M322M699M1.16B1.47B1.48B134M438M354.65M367.86M509.39M407.74M389.68M126.5M164.99M171.43M211.49M
Net Debt2.77B2.7B2.78B2.52B2.05B1.93B1.77B1.1B1.28B1.55B1.36B1.61B254M290M138M492M970M1.33B1.31B-212M287M292.12M321.43M473.15M364.05M352.94M-36.07M82.16M77.03M73.64M
Debt / Equity0.63x0.63x0.59x0.55x0.60x0.70x0.40x0.30x0.31x0.42x0.37x0.42x0.10x0.12x0.10x0.25x0.53x0.87x0.81x0.06x0.31x0.26x0.32x0.61x0.69x0.97x0.14x0.20x0.22x0.28x
Debt / EBITDA2.11x2.68x3.24x3.33x2.89x4.39x1.54x1.11x1.04x1.29x1.30x1.44x0.33x0.40x0.28x0.58x1.12x1.61x2.02x0.19x0.73x0.78x0.79x1.29x1.30x1.33x0.48x0.57x0.51x0.55x
Net Debt / EBITDA1.75x2.18x2.92x2.92x1.77x2.30x1.33x0.84x0.92x1.21x1.19x1.36x0.21x0.25x0.12x0.41x0.94x1.45x1.79x-0.30x0.48x0.64x0.69x1.20x1.16x1.20x-0.14x0.28x0.23x0.19x
Interest Coverage6.43x3.91x3.09x4.08x8.49x5.18x12.58x14.44x14.12x16.62x12.44x21.08x39.19x122.33x72.25x54.28x16.95x8.94x12.33x59.67x28.11x13.85x19.13x11.87x-18.54x24.25x13.68x13.19x18.87x
Total Equity5.29B5.26B5.22B5.26B5.57B5.28B5.14B4.87B4.64B3.96B3.97B4.04B4.05B3.88B3.19B2.77B2.18B1.7B1.82B2.17B1.44B1.35B1.14B833.21M589.18M399.84M892M805.38M762.08M745.11M
Equity Growth %0.46%0.92%-0.8%-5.55%5.47%2.68%5.48%4.95%17.33%-0.2%-1.83%-0.17%4.2%21.87%14.93%27.26%28.25%-6.44%-16.47%51.5%6.57%17.67%37.33%41.42%47.35%-55.18%10.76%5.68%2.28%19.24%
Book Value per Share12.1212.0123.8812.0212.6912.0611.7511.1410.618.879.098.988.938.627.126.244.923.823.914.613.042.862.451.751.270.912.041.771.671.65
Total Shareholders' Equity5.29B5.26B5.22B5.26B5.57B5.28B5.14B4.87B4.64B3.96B3.97B4.04B4.05B3.88B3.19B2.77B2.18B1.7B1.82B2.17B1.44B1.35B1.14B833.21M589.18M399.84M892M805.38M762.08M745.11M
Common Stock175M175M175M175M177M177M177M177M178M180M183M184M184M193M191M191M190M190M190M189M203M219.62M203.57M182.91M165.13M167.88M180.86M184.91M183.83M189.57M
Retained Earnings5.32B5.02B4.91B5.03B5.22B4.96B4.85B4.63B4.33B3.97B3.73B3.65B3.52B3.82B3.26B2.85B2.34B1.96B1.91B1.66B937M826.11M616.07M418.51M226.29M44.66M519.77M430.74M393.94M370.93M
Treasury Stock-515M-66M-94M-118M-120M-157M-189M-214M-257M-432M-294M-315M-322M-735M-766M-778M-794M-823M-637M-1M-4M-4M-2M0000000
Accumulated OCI20M0-385M-439M-328M-311M-306M-322M-211M-360M-244M-53M130M0000000000-416.47K-442.1M-475.56M-523.17M-473.23M-418.9M-401.58M
Minority Interest000000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Surgical tray capital intensity

Stable Asset Base Amid Restructuring

Based on reported financial statements, SNN has maintained a stable total asset base of approximately $10.5 billion as of 2025Q4, suggesting that the firm's ongoing 12-Point Plan is focused on operational efficiency rather than aggressive balance sheet expansion or significant divestiture of core productive assets.

The consistency in total assets over the last ten quarters indicates a mature business model where capital is primarily recycled into existing operations rather than deployed for rapid scaling. Investors should monitor whether this stability persists as the company attempts to refresh its trauma and extremities product lines.

Conservative Leverage Supports Financial Flexibility

According to recent SEC filings, SNN maintains a debt-to-equity ratio of 0.63 as of 2025Q4, a figure that appears conservative relative to industry peers and suggests that the company retains sufficient balance sheet capacity to fund strategic bolt-on acquisitions without overextending its credit profile.

The moderate debt load provides a defensive buffer against potential volatility in elective procedure volumes. While the debt level is manageable, the company's reliance on restructuring programs warrants ongoing scrutiny to ensure that debt service remains well-covered by the improving free cash flow generation.

Capital Intensity of Surgical Infrastructure

As reported in financial statements, net PPE has grown to $1.6 billion by 2025Q4, reflecting the capital-intensive nature of maintaining extensive surgical instrument sets and robotic platforms required to support the company's competitive position in the orthopaedic and sports medicine markets.

The high concentration of assets in surgical trays and equipment suggests that SNN's business model is structurally tied to physical presence in hospital operating rooms. This asset-heavy requirement creates a significant barrier to entry but also necessitates continuous reinvestment to prevent obsolescence of the installed base.

Liquidity Buffer Remains Adequately Positioned

Based on the provided quarterly data, SNN reported a current ratio of 2.57 in 2025Q4, which indicates a robust liquidity position that appears sufficient to cover short-term obligations and provide a cushion against potential disruptions in global supply chains or healthcare system demand.

The improvement in the current ratio from 1.77 in 2023Q4 suggests a more disciplined approach to working capital management. This liquidity profile provides management with the necessary flexibility to navigate the cyclical nature of elective surgical procedures without resorting to emergency financing.

Goodwill Impairment Risk Remains Persistent

As indicated by the balance sheet, goodwill remains a significant component of total assets at $3.1 billion, a figure that has stayed largely unchanged over the last ten quarters and warrants investigation for potential impairment risks if future growth targets are not met.

Given the competitive pressures in the orthopaedic segment, the carrying value of these intangible assets may be sensitive to changes in long-term growth assumptions. Investors should monitor whether the company's recent strategic initiatives successfully drive the returns necessary to justify this substantial goodwill balance.

SNN — Frequently Asked Questions

Quick answers to the most common questions about buying SNN stock.

What are the total assets of Smith & Nephew plc (SNN)?

As of 2025, Smith & Nephew plc (SNN) had total assets of $10.46B including $4.10B in current assets.

How much debt does Smith & Nephew plc (SNN) have?

Smith & Nephew plc (SNN) carries total debt of $3.33B, offset by $557.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Smith & Nephew plc?

Smith & Nephew plc (SNN) has total shareholders' equity (book value) of $5.29B ($12.12 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Smith & Nephew plc's current ratio and liquidity?

Smith & Nephew plc (SNN) reported a current ratio of 2.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.